You just read:

New Data on FORTEO® (teriparatide [rDNA origin] injection) Showed Reduced Risk for New Vertebral and Clinical Fractures in Postmenopausal Women with Severe Osteoporosis

News provided by

Eli Lilly and Company

Nov 09, 2017, 17:30 EST